However, we cannot exclude the possibility that another pathogenic gene(s) is involved in the development of PD in addition to MIDN. For example, MIDN deletion in the British population cohort (38 of 142 of study cases, and 4 of 47 of controls) spans EFNA2, encoding ephrin A2 protein (Fig. 1). This evidence concerns the gene MIDN and Parkinson disease.